ELITRA PHARMACEUTICALS INC
S-1, EX-27.1, 2000-09-05
Previous: ELITRA PHARMACEUTICALS INC, S-1, EX-23.1, 2000-09-05
Next: LODGIAN INC, DEFA14A, 2000-09-05



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>                     <C>                     <C>
<PERIOD-TYPE>                   5-MOS                   YEAR                   YEAR                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997             DEC-31-1998             DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JUL-18-1997             JAN-01-1998             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1997             DEC-31-1998             DEC-31-1999             JUN-30-2000
<CASH>                                              48                   1,306                   7,883                   6,247
<SECURITIES>                                         0                       0                   4,006                   5,022
<RECEIVABLES>                                        0                       0                       0                   1,150
<ALLOWANCES>                                         0                       0                       0                       0
<INVENTORY>                                          0                       0                       0                       0
<CURRENT-ASSETS>                                    48                   1,335                  12,058                  12,544
<PP&E>                                              31                   1,274                   2,988                   3,474
<DEPRECIATION>                                       0                      67                     370                     654
<TOTAL-ASSETS>                                      81                   2,594                  14,801                  22,917
<CURRENT-LIABILITIES>                              119                     609                   1,897                   3,258
<BONDS>                                              0                     827                   1,275                     923
                                0                       0                  16,384                  16,768
                                          0                       5                       5                       7
<COMMON>                                             1                       3                       4                       5
<OTHER-SE>                                        (41)                   1,155                 (4,579)                     334
<TOTAL-LIABILITY-AND-EQUITY>                        81                   2,594                  14,801                  22,917
<SALES>                                              0                       0                       0                       0
<TOTAL-REVENUES>                                     0                       0                       0                     287
<CGS>                                                0                       0                       0                       0
<TOTAL-COSTS>                                        0                       0                       0                       0
<OTHER-EXPENSES>                                    40                   1,750                   6,052                   5,990
<LOSS-PROVISION>                                     0                       0                       0                       0
<INTEREST-EXPENSE>                                   1                     (1)                   (266)                   (180)
<INCOME-PRETAX>                                   (41)                 (1,749)                 (5,786)                 (5,523)
<INCOME-TAX>                                         0                       0                       0                       0
<INCOME-CONTINUING>                               (41)                 (1,749)                 (6,170)                 (5,907)
<DISCONTINUED>                                       0                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0                       0
<CHANGES>                                            0                       0                       0                       0
<NET-INCOME>                                      (41)                 (1,749)                 (6,170)                 (5,907)
<EPS-BASIC>                                     (0.11)                  (2.55)                  (4.52)                  (2.93)
<EPS-DILUTED>                                   (0.11)                  (2.55)                  (4.52)                  (2.93)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission